Renaissance Technologies’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,344,652
| Closed | -$62.3M | – | 3880 |
|
|
2019
Q2 | $62.3M | Buy |
1,344,652
+1,047,084
| +352% | +$29.4M | 0.05% | 404 |
|
|
2019
Q1 | $7.25M | Buy |
+297,568
| New | +$6.2M | 0.01% | 1570 |
|
|
2018
Q3 | – | Sell |
-540,352
| Closed | -$9.07M | – | 3669 |
|
|
2018
Q2 | $9.07M | Buy |
540,352
+67,400
| +14% | +$1.07M | 0.01% | 1413 |
|
|
2018
Q1 | $7.72M | Sell |
472,952
-239,719
| -34% | -$3.84M | 0.01% | 1540 |
|
|
2017
Q4 | $9.12M | Buy |
+712,671
| New | +$8.11M | 0.01% | 1441 |
|
|
2017
Q3 | – | Sell |
-990,441
| Closed | -$8.29M | – | 3473 |
|
|
2017
Q2 | $8.29M | Buy |
+990,441
| New | +$8.1M | 0.01% | 1399 |
|
|
2016
Q4 | – | Sell |
-424,452
| Closed | -$2.87M | – | 3591 |
|
|
2016
Q3 | $2.87M | Buy |
424,452
+407,000
| +2,332% | +$1.57M | 0.01% | 1980 |
|
|
2016
Q2 | $62K | Sell |
17,452
-2,137,200
| -99% | -$6.96M | ﹤0.01% | 3219 |
|
|
2016
Q1 | $6.36M | Sell |
2,154,652
-1,055,742
| -33% | -$3.16M | 0.01% | 1459 |
|
|
2015
Q4 | $13.5M | Buy |
3,210,394
+2,280,966
| +245% | +$10.4M | 0.03% | 779 |
|
|
2015
Q3 | $4.24M | Buy |
929,428
+117,433
| +14% | +$696K | 0.01% | 1507 |
|
|
2015
Q2 | $5.85M | Sell |
811,995
-242,657
| -23% | -$1.79M | 0.01% | 1337 |
|
|
2015
Q1 | $7.77M | Buy |
+1,054,652
| New | +$7.51M | 0.02% | 1097 |
|
|
2014
Q4 | – | Sell |
-14,852
| Closed | -$53K | – | 3210 |
|
|
2014
Q3 | $53K | Buy |
+14,852
| New | +$58.5K | ﹤0.01% | 2708 |
|
|
2014
Q1 | – | Sell |
-363,852
| Closed | -$1.82M | – | 3113 |
|
|
2013
Q4 | $1.82M | Sell |
363,852
-222,900
| -38% | -$1.21M | ﹤0.01% | 1798 |
|
|
2013
Q3 | $3.65M | Buy |
+586,752
| New | +$3.49M | 0.01% | 1335 |
|
Other funds holding ARRY
Renaissance Technologies's ARRY Position: Q3 2019 in Review
Renaissance Technologies sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,344,652 shares — an estimated $62.3M sold.
Renaissance Technologies first reported a position in ARRY in Q3 2013 and held it in 16 quarters. The position peaked at $62.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Renaissance Technologies reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Renaissance Technologies sold 1,344,652 Array Biopharma Inc shares in Q3 2019, an estimated $62.3M.
- Renaissance Technologies first reported a position in Array Biopharma Inc in Q3 2013 and held it in 16 quarters.
- Renaissance Technologies's Array Biopharma Inc position peaked at $62.3M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.